RxDoctor Payments Data

John Yates, PA

Medical · Etowah, TNNPI 1245821438

Payments from drug & device makers

$2,522in general payments, 2019–2025

Across 156 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$402
  • AbbVie$397
  • Novo Nordisk$273
  • Bayer$239
  • AstraZeneca$238
  • Amgen$227
  • plus $747 from 17 others

What the payments were for

  • Food & beverage$2,522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,522 in reported general payments places this provider in the 75th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$78,537
Medicare patients
377
Services billed
5,280

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide28$27,554
EliquisApixaban37$22,163
OzempicSemaglutide16$15,421
EntrestoSacubitril/Valsartan13$7,950
Albuterol Sulfate HfaAlbuterol Sulfate55$1,137
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav85$899
Ezetimibe28$758
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort11$608
Sucralfate17$598
Famotidine24$586
Gabapentin39$585
Losartan Potassium63$536
Valsartan22$514
Doxycycline Hyclate64$479
Prednisone192$432

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$402$27,55428 claims
PfizerEliquis$20$22,16337 claims
Novo NordiskOzempic$273$15,42116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 480 medical providers in Tennessee.

Other medical in Etowah

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →